Patients
After obtaining approval of our institutional review board (IRB
#:19KHCC34), we retrospectively reviewed all patients who presented
with T-ALL to our department from January 2005 until April 2020.
Patients’ records were identified by querying our departmental database.
All patients with T-ALL presented to our institution and treated per
modified St Jude Total VX protocol; we excluded patients who presented
with relapsed disease, received previous therapy before referral and
patients who underwent hematopoietic cell transplantation (HCT) in first
remission.